EP1933869
Notkun á lL-23 og lL-17 mótlyfjum til að meðhöndla augnbólgu sjálfsofnæmissjúkdóm.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
30.8.2006EP published:
14.10.2009EP application number:
06813945.0
EP translation filed:
19.1.2010Grant published:
15.2.2010EPO information:
European Patent Register
Max expiry date:
29.8.2026Expiry date:
29.8.2013
Title:
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
Timeline
Today
30.8.2006EP application
14.10.2009EP Publication
19.1.2010Translation submitted
15.2.2010Registration published
29.8.2013Expires
Owner
Name:
Merck Sharp & Dohme Corp., (a New Jersey corporation)Address:
126 East Lincoln Avenue, 07065, Rahway, NJ, US
Name:
The Government of the United States of America as represented by The Secretary of the Department of Health and Human ServicesAddress:
National Institutes of Health Office of Technology Transfer Suite 325, 6011 Executive Boulevard, 20852-3804, Rockville, MD, US
Inventor
Name:
CUA, Daniel, J.Address:
Boulder Creek, CA, US
Name:
KASTELEIN, Robert, A.Address:
Redwood City, CA, US
Name:
TSAI, Van, T.Address:
San Diego, CA, US
Name:
CASPI, RachelAddress:
Bethesda, MD, US
Name:
SILVER, PhyllisAddress:
Silver Spring, MD, US
Name:
LUGER, DrorAddress:
Rockville, MD, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
713792 PDate:
1.9.2005Country:
US
Number:
837312 PDate:
11.8.2006Country:
US
Classification
Categories:
A61K 39/395, A61P 27/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 21.7.2010
Expires: 31.8.2011
Payer: Örn Þór, slf.
Number: 6
Paid: 22.7.2011
Expires: 29.8.2012
Payer: Örn Þór, slf.
Number: 7
Paid: 19.7.2012
Expires: 29.8.2013
Payer: Örn Þór, slf.